PMID- 27008069
OWN - NLM
STAT- MEDLINE
DCOM- 20161109
LR  - 20220330
IS  - 1758-8111 (Electronic)
IS  - 1758-8103 (Linking)
VI  - 6
IP  - 2
DP  - 2016 Apr
TI  - Treatment satisfaction with different weight loss methods among respondents with 
      obesity.
PG  - 161-70
LID - 10.1111/cob.12140 [doi]
AB  - Satisfaction with weight loss (WL) methods has been correlated with the 
      effectiveness, long-term compliance and commitment to weight management. This 
      study explored treatment satisfaction associated with different WL methods among 
      patients with obesity. Cross-sectional data were analysed from the 2012 US 
      National Health and Wellness Survey. Respondents with obesity were categorized as 
      having a WL procedure (e.g., gastric bypass and gastric banding) or using a 
      prescription medication for WL (Sur/Rx), vs. using self-modification WL 
      techniques (e.g., diet, exercise and WL supplements). Overall satisfaction with 
      current WL methods was assessed among the obese and the overweight/obese with 
      type 2 diabetes mellitus (T2DM). Of the 22 927 respondents with obesity, 58.4% 
      took no current action to lose weight, 2.3% were identified as Sur/Rx and 39.3% 
      were identified as self-modification. The Sur/Rx group reported being 
      very/extremely satisfied more frequently than the self-modification group (39.3% 
      vs. 20.2%, P < 0.001). Similarly, respondents with T2DM that were 
      overweight/obese reported higher satisfaction in the Sur/Rx vs. the 
      self-modification group (46.6% vs. 22.7%, P < 0.001). Satisfaction with WL 
      methods was greater for the Sur/Rx vs. the self-modification group. Data suggest 
      the importance of including bariatric surgery and pharmacotherapy as an integral 
      part in comprehensive WL management.
CI  - (c) 2016 World Obesity.
FAU - Gupta, S
AU  - Gupta S
AD  - Health Outcomes Practice, Kantar Health, Princeton, NJ, USA.
FAU - Wang, Z
AU  - Wang Z
AD  - Health Economics & Outcomes Research, Eisai, Inc., Woodcliff Lake, NJ, USA.
LA  - eng
PT  - Journal Article
PL  - England
TA  - Clin Obes
JT  - Clinical obesity
JID - 101560587
RN  - 0 (Anti-Obesity Agents)
SB  - IM
MH  - Anti-Obesity Agents/therapeutic use
MH  - Bariatric Surgery
MH  - Diabetes Mellitus, Type 2/complications
MH  - Diet, Reducing
MH  - Exercise Therapy
MH  - Female
MH  - Humans
MH  - Life Style
MH  - Male
MH  - Middle Aged
MH  - Obesity/complications/*therapy
MH  - *Patient Satisfaction
MH  - Weight Loss
OTO - NOTNLM
OT  - Body mass index
OT  - type 2 diabetes
OT  - weight loss medication
OT  - weight loss satisfaction
EDAT- 2016/03/24 06:00
MHDA- 2016/11/10 06:00
CRDT- 2016/03/24 06:00
PHST- 2015/11/16 00:00 [received]
PHST- 2016/01/21 00:00 [revised]
PHST- 2016/01/26 00:00 [accepted]
PHST- 2016/03/24 06:00 [entrez]
PHST- 2016/03/24 06:00 [pubmed]
PHST- 2016/11/10 06:00 [medline]
AID - 10.1111/cob.12140 [doi]
PST - ppublish
SO  - Clin Obes. 2016 Apr;6(2):161-70. doi: 10.1111/cob.12140.